July 12 (Reuters) - Agile Therapeutics Inc AGRX.O :
* AGILE THERAPEUTICS UPDATES SECOND QUARTER 2022 GUIDANCE
* AGILE THERAPEUTICS INC - Q2 OPERATING EXPENSES (OPEX)
EXPECTED
TO BE BELOW GUIDED RANGE
* AGILE THERAPEUTICS - PREVIOUSLY GUIDED TWIRLA DEMAND FOR
Q2 TO
BE 20,000 TO 22,000 CYCLES AND NOW BELIEVES DEMAND WILL BE AT
MID-POINT OF THAT RANGE
* AGILE THERAPEUTICS INC - UPDATED TWIRLA DEMAND GUIDANCE
REFLECTS
CONTINUED PROGRESS MADE IN BOTH RETAIL AND NON-RETAIL CHANNELS
Source text for Eikon: ID:nGNXXhGmf
Further company coverage: AGRX.O
((reuters.briefs@thomsonreuters.com;))